Katya Schwenk / The LeverFeb 22, 2024
The government is trying to make good on its promise to regulate overpriced prescription drugs, but private equity doesn't want to lose its extremely lucrative income stream. Dig deeper ( 7 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.